首页> 外文期刊>Journal of computer assisted tomography >Hepatocellular carcinoma after systemic chemotherapy: gadolinium-enhanced mr measurement of necrosis by volume histogram.
【24h】

Hepatocellular carcinoma after systemic chemotherapy: gadolinium-enhanced mr measurement of necrosis by volume histogram.

机译:全身化疗后的肝细胞癌:通过体积直方图测量g增强的MR测量坏死。

获取原文
获取原文并翻译 | 示例
           

摘要

As a preliminary study, we measured the necrosis of advanced hepatocellular carcinoma (HCC) by volume histogram after systemic chemotherapy and correlated it with clinical data. Five patients with advanced HCC secondary to chronic hepatitis and cirrhosis underwent pretreatment and posttreatment MR examination on a 1.5 T MR scanner following systemic chemotherapy. MR sequences included dynamic enhanced fast spoiled gradient echo 3D images. Clinical response to chemotherapy, as determined by MR images, was measured as changes of both the total tumor volume and the percent of tumor necrosis by volume histogram algorithm. Four of five patients had clinical improvement. Three of these patients had no or minimal change of tumor volume; however, there was an increase in tumor necrosis in follow-up MR image. One patient of five with no change in tumor necrosis had no response and died at 3 months. Serial MR images showed increased irregular necrosis of advanced HCC after systemic chemotherapy, but stable volume, in patients who responded clinically to systemic chemotherapy.
机译:作为一项初步研究,我们通过全身化疗后的体积直方图测量了晚期肝细胞癌(HCC)的坏死程度,并将其与临床数据相关联。 5例继发于慢性肝炎和肝硬化的晚期HCC患者在系统化疗后接受了1.5 T MR扫描仪的治疗前和治疗后MR检查。 MR序列包括动态增强的快速损坏的梯度回波3D图像。由MR图像确定的对化学疗法的临床反应通过体积直方图算法测量为总肿瘤体积和肿瘤坏死百分比的变化。五分之四的患者有临床改善。其中三例患者的肿瘤体积无变化或变化很小。然而,在后续的MR图像中,肿瘤坏死的增加。五名患者中无肿瘤坏死改变的一名患者无反应,并在3个月时死亡。串联MR图像显示,在对全身化学疗法临床反应的患者中,全身化疗后晚期HCC的不规则坏死增加,但体积稳定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号